Cibus, Inc. (CBUS)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Cibus (CBUS) shareholders vote on board, pay, and independent auditor
# 📢 What This Document Is 🗓️ This document is a Proxy Statement (DEF 14A), which is essentially an official invitation and rulebook for an Annual Meeting of Stockholders. 📑 Its entire purpose is to explain what matters will be voted on, who the directors are, and how stockholders can cast their v
SEC filings
All filings →Insider trades
All insider trades →Cibus, Inc. has no reported insider trades in the last 90 days.